UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                       Pursuant to section 13 or 15(d) of
                       the Securities exchange act of 1934


Date of Report (Date of earliest event reported): January 20, 1997



                            MERIS LABORATORIES, INC.
--------------------------------------------------------------------------------
            (Exact name of registrant as specified in its charter)



                                   California
--------------------------------------------------------------------------------
         (State or other jurisdiction of incorporation or organization)


         0-19360                                   77-0274078
---------------------------           ------------------------------------------
  (Commission file number)              (I.R.S. Employer Identification No.)



   2890 Zanker Road, San Jose, California                    95134
--------------------------------------------------------------------------------
  (Address of principal executive offices)                (Zip Code)


Registrant's telephone number, including area code:  408-434-9200



                               Not Applicable
--------------------------------------------------------------------------------
      (Former name or former address, if changed since last report)

                                                    
                                       1
<PAGE>


Item 5.    Other Events

     Effective  January 20, 1997, the Company's  common stock has been de-listed
from the Nasdaq  National  Market due to its  inability to meet  certain  Nasdaq
minimum listing requirements.  As a result, Nasdaq will notify the market makers
that the Company's  common stock has defaulted into the National  Association of
Securities Dealers,  Inc. (NASD) OTC Bulletin Board where it may be traded. (See
Exhibit A for the press release issued for this event.)













                                                     
                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.


                                      MERIS LABORATORIES, INC.


                          By:          /s/ Thurman Jordan
                                      --------------------------------------
                                      Thurman Jordan
                                      Senior Vice President - Finance
                                      (Duly authorized Officer and Principal
                                      Financial and Accounting Officer)

Date: January 21, 1997












                                       2

<PAGE>

                                   EXHIBIT A




FOR IMMEDIATE RELEASE
---------------------                      Contact: William McCormick
                                                    President & CEO
                                                    (408) 434-9200 x3710

                                                    Thurman Jordan
                                                    Senior Vice President,
                                                    Finance and CFO
                                                    (408) 434-9200 x3722


                     MERIS LABORATORIES, INC. ANNOUNCES ITS
               COMMON STOCK DE-LISTED FROM NASDAQ NATIONAL MARKET
                             

     San Jose, CA., January 20, 1997 - Meris Laboratories,  Inc. (Nasdaq - MERS)
announced that,  effective  today,  its common stock has been de-listed from the
Nasdaq  National  Market due to its  inability  to meet certain  Nasdaq  minimum
listing requirements. As a result, Nasdaq will notify the market makers that the
Company's common stock has defaulted into the National Association of Securities
Dealers, Inc. (NASD) OTC Bulletin Board where it may be traded.



                                      # # #





















                                       3
[{"type": "8-K", "sequence": "1", "description": "CURRENT REPORT", "secsgml_size_bytes": 4287}]
{"company-data": {"conformed-name": "MERIS LABORATORIES INC", "cik": "0000875620", "assigned-sic": "8071", "irs-number": "770274078", "state-of-incorporation": "CA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-19360", "film-number": "97508077"}, "business-address": {"street1": "2890 ZANKER RD", "city": "SAN JOSE", "state": "CA", "zip": "95134", "phone": "4084349200"}, "mail-address": {"street1": "2890 ZANKER RD", "city": "SAN JOSE", "state": "CA", "zip": "95134"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                       Pursuant to section 13 or 15(d) of
                       the Securities exchange act of 1934

Date of Report (Date of earliest event reported): January 20, 1997

                            MERIS LABORATORIES, INC.
--------------------------------------------------------------------------------
            (Exact name of registrant as specified in its charter)

                                   California
--------------------------------------------------------------------------------
         (State or other jurisdiction of incorporation or organization)

         0-19360                                   77-0274078
---------------------------           ------------------------------------------
  (Commission file number)              (I.R.S. Employer Identification No.)

   2890 Zanker Road, San Jose, California                    95134
--------------------------------------------------------------------------------
  (Address of principal executive offices)                (Zip Code)

Registrant's telephone number, including area code:  408-434-9200

                               Not Applicable
--------------------------------------------------------------------------------
      (Former name or former address, if changed since last report)

                                                    
                                       1
Item 5.    Other Events

     Effective  January 20, 1997, the Company's  common stock has been de-listed
from the Nasdaq  National  Market due to its  inability to meet  certain  Nasdaq
minimum listing requirements.  As a result, Nasdaq will notify the market makers
that the Company's  common stock has defaulted into the National  Association of
Securities Dealers,  Inc. (NASD) OTC Bulletin Board where it may be traded. (See
Exhibit A for the press release issued for this event.)

                                                     
                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

                                      MERIS LABORATORIES, INC.

                          By:          /s/ Thurman Jordan
                                      --------------------------------------
                                      Thurman Jordan
                                      Senior Vice President - Finance
                                      (Duly authorized Officer and Principal
                                      Financial and Accounting Officer)

Date: January 21, 1997

                                       2
EXHIBIT A

FOR IMMEDIATE RELEASE
---------------------                      Contact: William McCormick
                                                    President & CEO
                                                    (408) 434-9200 x3710

                                                    Thurman Jordan
                                                    Senior Vice President,
                                                    Finance and CFO
                                                    (408) 434-9200 x3722

                     MERIS LABORATORIES, INC. ANNOUNCES ITS
               COMMON STOCK DE-LISTED FROM NASDAQ NATIONAL MARKET
                             

     San Jose, CA., January 20, 1997 - Meris Laboratories,  Inc. (Nasdaq - MERS)
announced that,  effective  today,  its common stock has been de-listed from the
Nasdaq  National  Market due to its  inability  to meet certain  Nasdaq  minimum
listing requirements. As a result, Nasdaq will notify the market makers that the
Company's common stock has defaulted into the National Association of Securities
Dealers, Inc. (NASD) OTC Bulletin Board where it may be traded.

                                      # # #

                                       3